Education and Support After Progression ALK Inhibitors

Patient Education and Transition Between Therapies

Key Themes:

• Approaches to patient education after disease progression
• Real-world challenges during therapy transitions
• Current options for patients progressing on lorlatinib

Notable Insights:

• Castronovo outlined approaches to patient education when discussing next steps after progression
• Grizzard identified real-world challenges patients face when transitioning between therapies
• Dr Dietrich presented current best options for patients progressing on lorlatinib